Glioblastoma multiforme is one of the most lethal and treatment-resistant of human tumors. Among the therapeutic triad of surgery, radiation therapy, and chemotherapy, only radiation therapy has been shown to improve survival.1 Despite 30 years of intensive efforts to find an effective chemotherapy regimen for glioblastoma multiforme, the median survival of 12 to 15 months has not changed appreciably since the introduction of radiation therapy.
No takes yet. Share an insight, caveat, or question.
John W. Henson (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: